Detalles de la búsqueda
1.
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective.
Semin Cancer Biol
; 86(Pt 3): 997-1007, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838957
2.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759721
3.
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
Mol Med
; 29(1): 14, 2023 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717774
4.
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 23(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35055006
5.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024268
6.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
7.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
8.
Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis.
Int J Colorectal Dis
; 35(2): 337-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823050
9.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723313
10.
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial.
Front Oncol
; 13: 1069370, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860319
11.
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model.
Cell Death Discov
; 9(1): 116, 2023 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019893
12.
Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis.
Microorganisms
; 11(5)2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317121
13.
Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer.
Crit Rev Oncol Hematol
; 173: 103657, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337969
14.
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941.
Cancers (Basel)
; 14(16)2022 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36011056
15.
Immunotherapy in advanced anal cancer: Is the beginning of a new era?
Cancer Treat Rev
; 105: 102373, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279535
16.
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.
Biomed Pharmacother
; 151: 113163, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617803
17.
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Cancer Treat Rev
; 103: 102326, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35016085
18.
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.
Int J Cancer
; 129(3): 536-45, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21064098
19.
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
Biomolecules
; 11(5)2021 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925948
20.
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).
Curr Oncol
; 28(3): 1761-1772, 2021 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066784